登录

Lead Medical Landed 30 Million Yuan Series A Financing

作者: Mailman 2019-09-23 18:16
领治医学
http://www.leadmed.cn
企业数据由 动脉橙 提供支持
生物医药研发商 | A轮 | 运营中
中国-广东
2019-09-20
融资金额:RMB¥3000万
磁晅资本
查看

According to Yiou, on September 20, 2019, Shenzhen Lead Medical Technology Co., Ltd (Lead Medical), a company explored in micro-ecological health management, announced the completion of 30 million yuan A round of financing, invested by Hangzhou (China) Magsun Investment Co., Ltd. (Magsun). This financing will mainly be used to expand the capacity of the micro-ecological laboratory, build more health management centers, and recruit and train staff.


Founded in 2013 and headquartered in Shenzhen, Lead Medical focuses on the prevention and management of chronic diseases and sub-health by means of intestinal metagenomic sequencing analysis, in-depth development of intestinal micro-ecological targeted opsonization, optimization of intestinal flora structure and biomedical big data analysis. At present, Lead Medical has established 16 micro-ecological health management institutions in Shenzhen, Xi 'an, Anqing, Changsha, Harbin, Qingdao, and other cities.


The health management service that Lead Medical provides is based on personalized conditioning. According to Yue peng, the president of Lead Medical, the intestinal flora structure is diverse in individuals, so everyone's treatment plan is different. At present, Lead Medical adopts biweekly intestinal metagene tests to develop the client's conditioning plan at each stage.


In terms of research technology, Lead Medical has 7 invention patents and 13 computer software copyrights. In addition, five more patents are pending. The company has launched five conditioning plans, including “beautiful mother plan”, “caring parents plan”, “safe hypoglycemic plan”, “elite health plan” and “micro-ecological health care plan”.


>>>>
About Magsun


Founded in 2016, Magsun is a leading comprehensive investment company in China, focusing on mergers and acquisitions as well as providing professional services to help enterprises update from traditional business to e-business. Magsun has two PE funds, managing more than 4 billion RMB assets. Moreover, the company has successfully made strategic equity participation with several listed companies.


Currently, Magsun has developed its unique business structure with three business models together, including M&A with the listed companies, VC/PE, and transformation of traditional business to e-business. 

相关赛道 生物制药
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

解构阿斯利康中金的15个项目,聚焦创新与合作,生态圈版图正徐徐铺开

Xunminkang Biotechnology Snares ¥10M in Series A Round

Genome Wisdom Raises $85M in Series B Financing, Developing the Next Generation of Pathological Diagnosis of Tumors

Genetron Snags $71M for Genomics-Oncology Services

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

培养养老服务消费新业态!民政部印发《关于进一步扩大养老服务供给 促进养老服务消费的实施意见》

2019-09-23
下一篇

总体规模超过5万亿元!工信部发布《关于促进老年用品产业发展的指导意见(征求意见稿)》

2019-09-23